Maravai Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Maravai Lifesciences Holdings
MRVI Stock  USD 5.05  0.02  0.40%   
Maravai Lifesciences financial statements provide useful quarterly and yearly information to potential Maravai Lifesciences Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Maravai Lifesciences financial statements helps investors assess Maravai Lifesciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Maravai Lifesciences' valuation are summarized below:
Gross Profit
128.4 M
Profit Margin
(0.81)
Market Capitalization
1.3 B
Enterprise Value Revenue
2.7555
Revenue
276.9 M
We have found one hundred twenty available fundamental ratios for Maravai Lifesciences, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of Maravai Lifesciences last-minute fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The Maravai Lifesciences' current Market Cap is estimated to increase to about 2.8 B. The Maravai Lifesciences' current Enterprise Value is estimated to increase to about 3.1 B

Maravai Lifesciences Total Revenue

462.41 Million

Check Maravai Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Maravai Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.8 M, Interest Expense of 33.9 M or Selling General Administrative of 103.3 M, as well as many indicators such as Price To Sales Ratio of 3.27, Dividend Yield of 0.0157 or PTB Ratio of 2.27. Maravai financial statements analysis is a perfect complement when working with Maravai Lifesciences Valuation or Volatility modules.
  
Check out the analysis of Maravai Lifesciences Correlation against competitors.

Maravai Lifesciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.5 B1.7 B974.1 M
Slightly volatile
Short and Long Term Debt Total559.4 M702.6 M439.5 M
Slightly volatile
Other Current Liabilities55.1 M68.5 M40.9 M
Slightly volatile
Total Current Liabilities89.4 M100.6 M60.3 M
Slightly volatile
Total Stockholder Equity302.8 M479.3 M224.3 M
Slightly volatile
Other Liabilities405.2 M797.4 M242.8 M
Slightly volatile
Property Plant And Equipment Net268.8 M256 M93.1 M
Slightly volatile
Current Deferred Revenue2.9 M3 M7 M
Pretty Stable
Accounts Payable7.1 M12.3 M5.5 M
Slightly volatile
Cash374.2 M661.2 M203.2 M
Slightly volatile
Non Current Assets Total979.4 M905.7 M694.7 M
Slightly volatile
Non Currrent Assets Other19.9 M10.7 M9.1 M
Slightly volatile
Other Assets973.4 M927 M298.1 M
Slightly volatile
Long Term Debt506.8 M596.5 M409.5 M
Slightly volatile
Cash And Short Term Investments374.2 M661.2 M203.2 M
Slightly volatile
Net Receivables74.3 M64.1 M42 M
Slightly volatile
Good Will263.1 M374.9 M241.7 M
Slightly volatile
Common Stock Total Equity2.2 M2.3 M115.2 M
Slightly volatile
Common Stock Shares Outstanding170 M151.7 M122.5 M
Slightly volatile
Liabilities And Stockholders Equity1.5 B1.7 B974.1 M
Slightly volatile
Non Current Liabilities Total898.5 M701.6 M584.2 M
Slightly volatile
Capital Lease Obligations104.8 M99.8 M29.9 M
Slightly volatile
Inventory38.1 M59.1 M26.2 M
Slightly volatile
Other Current Assets14.6 M20.5 M8 M
Slightly volatile
Other Stockholder Equity90.2 M147.8 M47.7 M
Slightly volatile
Total Liabilities987.9 M802.2 M644.5 M
Slightly volatile
Net Invested Capital814.7 M1.1 B637.5 M
Slightly volatile
Property Plant And Equipment Gross307.7 M293.1 M101.1 M
Slightly volatile
Short and Long Term Debt5.1 M6.3 M3.7 M
Slightly volatile
Total Current Assets501.2 M804.9 M279.4 M
Slightly volatile
Capital Stock2.1 M2.3 M115.2 M
Slightly volatile
Non Current Liabilities Other2.6 M2.8 M50.4 M
Pretty Stable
Net Working Capital411.8 M704.3 M219.1 M
Slightly volatile
Short Term Debt9.2 M14.8 M5.9 M
Slightly volatile
Intangible Assets210.6 M254.1 M209.9 M
Pretty Stable
Common Stock2.1 M2.3 M115.2 M
Slightly volatile
Property Plant Equipment88.2 M134.1 M67.5 M
Slightly volatile
Deferred Long Term Liabilities2.2 M2 M3 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity183.9 M206.9 M225.6 M
Slightly volatile
Retained Earnings Total Equity147.6 M166.1 M181.1 M
Slightly volatile
Long Term Debt Total419.7 M472.1 M514.8 M
Slightly volatile
Capital Surpluse102.7 M115.5 M126 M
Slightly volatile

Maravai Lifesciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization33.8 M56.1 M28.3 M
Slightly volatile
Interest Expense33.9 M52.8 M30.7 M
Slightly volatile
Selling General Administrative103.3 M172.6 M73 M
Slightly volatile
Total Revenue462.4 M332.3 M269.2 M
Slightly volatile
Gross Profit153.2 M161.2 M167.2 M
Slightly volatile
Other Operating Expenses238.6 M368.7 M172.5 M
Slightly volatile
EBIT801.3 M763.2 M228.4 M
Slightly volatile
Research Development12.5 M19.9 M8.5 M
Slightly volatile
EBITDA860.2 M819.3 M258.3 M
Slightly volatile
Cost Of Revenue122 M171.1 M90.3 M
Slightly volatile
Total Operating Expenses116.6 M197.6 M82.2 M
Slightly volatile
Reconciled Depreciation33.2 M52.7 M27.9 M
Slightly volatile
Non Operating Income Net Other223.2 K251.1 K273.8 K
Slightly volatile

Maravai Lifesciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation41.8 M39.8 M11.9 M
Slightly volatile
Begin Period Cash Flow763.3 M727 M204.3 M
Slightly volatile
Depreciation33.7 M56.1 M28.3 M
Slightly volatile
Dividends Paid250.8 M176.5 M128.9 M
Slightly volatile
Capital Expenditures79.2 M75.4 M20.4 M
Slightly volatile
End Period Cash Flow374.2 M661.2 M203.2 M
Slightly volatile
Cash And Cash Equivalents Changes252.1 M283.7 M309.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.273.4415.0346
Slightly volatile
Dividend Yield0.01570.01760.0192
Slightly volatile
PTB Ratio2.272.3815.1227
Slightly volatile
Days Sales Outstanding45.7863.3551.85
Slightly volatile
Book Value Per Share2.985.392.7538
Slightly volatile
Average Payables4.3 M5 M5.2 M
Pretty Stable
Stock Based Compensation To Revenue0.110.11970.0392
Slightly volatile
Capex To Depreciation1.271.210.5014
Slightly volatile
PB Ratio2.272.3815.1227
Slightly volatile
EV To Sales3.43.5816.7368
Slightly volatile
ROIC0.00430.00450.0569
Pretty Stable
Inventory Turnover3.833.333.8761
Slightly volatile
Days Of Inventory On Hand89.2411497.4766
Slightly volatile
Payables Turnover14.912.4817.1281
Very volatile
Sales General And Administrative To Revenue0.260.30.3261
Slightly volatile
Research And Ddevelopement To Revenue0.05650.05380.0372
Slightly volatile
Capex To Revenue0.210.20.0717
Slightly volatile
Cash Per Share2.263.921.5661
Slightly volatile
Days Payables Outstanding25.0530.2822.8199
Pretty Stable
Intangibles To Total Assets0.470.420.6277
Slightly volatile
Current Ratio3.967.23.301
Slightly volatile
Receivables Turnover7.195.967.1471
Slightly volatile
Graham Number6.757.215.3862
Slightly volatile
Shareholders Equity Per Share1.872.841.9843
Slightly volatile
Debt To Equity2.941.692.4675
Very volatile
Capex Per Share0.470.450.1551
Slightly volatile
Revenue Per Share2.891.972.3546
Slightly volatile
Interest Debt Per Share3.924.484.4272
Slightly volatile
Debt To Assets0.50.470.5453
Slightly volatile
Enterprise Value Over EBITDA1.381.4556.8656
Slightly volatile
Operating Cycle135177149
Slightly volatile
Price Book Value Ratio2.272.3815.1227
Slightly volatile
Days Of Payables Outstanding25.0530.2822.8199
Pretty Stable
Company Equity Multiplier6.64.14.7883
Slightly volatile
Long Term Debt To Capitalization0.720.640.68
Slightly volatile
Total Debt To Capitalization0.740.680.6926
Pretty Stable
Debt Equity Ratio2.941.692.4675
Very volatile
Quick Ratio3.66.672.8798
Slightly volatile
Cash Ratio6.215.922.4026
Slightly volatile
Cash Conversion Cycle117153127
Slightly volatile
Days Of Inventory Outstanding89.2411497.4766
Slightly volatile
Days Of Sales Outstanding45.7863.3551.85
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.530.5511.771
Slightly volatile
Price To Book Ratio2.272.3815.1227
Slightly volatile
Fixed Asset Turnover1.111.173.6812
Pretty Stable
Enterprise Value Multiple1.381.4556.8656
Slightly volatile
Debt Ratio0.50.470.5453
Slightly volatile
Price Sales Ratio3.273.4415.0346
Slightly volatile
Asset Turnover0.220.170.2453
Pretty Stable
Gross Profit Margin0.520.440.5571
Slightly volatile
Price Fair Value2.272.3815.1227
Slightly volatile

Maravai Lifesciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.8 B2.2 B2.5 B
Slightly volatile
Enterprise Value3.1 B2.1 B2.7 B
Slightly volatile

Maravai Fundamental Market Drivers

Forward Price Earnings370.3704
Cash And Short Term Investments575 M

Maravai Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Maravai Lifesciences Financial Statements

Investors use fundamental indicators, such as Maravai Lifesciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Maravai Lifesciences' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue3 M2.9 M
Total Revenue332.3 M462.4 M
Cost Of Revenue171.1 M122 M
Stock Based Compensation To Revenue 0.12  0.11 
Sales General And Administrative To Revenue 0.30  0.26 
Research And Ddevelopement To Revenue 0.05  0.06 
Capex To Revenue 0.20  0.21 
Revenue Per Share 1.97  2.89 
Ebit Per Revenue(0.10)(0.09)

Currently Active Assets on Macroaxis

FFord Motor
GMGeneral Motors
SSentinelOne
GOOGAlphabet Inc Class C
WDWalker Dunlop
When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:
How To Invest In Maravai
Details
Is Maravai Stock a good investment?
Details
What is Maravai Lifesciences' Net Worth?
Details
Largest Life Sciences Tools & Services Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Maravai Lifesciences Correlation against competitors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.33)
Earnings Share
(1.67)
Revenue Per Share
2.044
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.02)
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY